The Promise of CAR T-Cell Therapy
Medical Health News,
Chimeric Antigen T-cell therapy or CAR T-cell therapy is one of the most promising types of immunotherapy.
Chimeric Antigen T-cell therapy or CAR T-cell therapy is one of the most promising types of immunotherapy.
EAST HANOVER, N.J., Oct. 29, 2018 /PRNewswire/ -- Novartis was awarded the 2018 Prix Galien USA Award for Best Biotechnology…
-- Kymriah was the first CAR-T cell therapy to ever be approved by a regulatory authority -- Since 1970, more than 40 Novartis…
SOURCE Novartis -- Kymriah was the first CAR-T cell therapy to ever be approved by a regulatory authority -- Since 1970, more…